Compare TTK HEALTHCARE with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DIVIS LABORATORIES TTK HEALTHCARE/
DIVIS LABORATORIES
 
P/E (TTM) x 16.9 34.3 49.4% View Chart
P/BV x 1.4 6.6 20.6% View Chart
Dividend Yield % 1.1 0.9 122.7%  

Financials

 TTK HEALTHCARE   DIVIS LABORATORIES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
DIVIS LABORATORIES
Mar-19
TTK HEALTHCARE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,2151,639 74.1%   
Low Rs6101,115 54.7%   
Sales per share (Unadj.) Rs444.4186.3 238.5%  
Earnings per share (Unadj.) Rs17.251.0 33.8%  
Cash flow per share (Unadj.) Rs27.657.3 48.2%  
Dividends per share (Unadj.) Rs5.0016.00 31.3%  
Dividend yield (eoy) %0.51.2 47.2%  
Book value per share (Unadj.) Rs177.9261.8 68.0%  
Shares outstanding (eoy) m14.13265.47 5.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.17.4 27.8%   
Avg P/E ratio x52.927.0 195.8%  
P/CF ratio (eoy) x33.024.0 137.5%  
Price / Book Value ratio x5.15.3 97.5%  
Dividend payout %29.031.4 92.3%   
Avg Mkt Cap Rs m12,894365,592 3.5%   
No. of employees `0002.311.8 19.5%   
Total wages/salary Rs m1,3075,423 24.1%   
Avg. sales/employee Rs Th2,715.74,175.1 65.0%   
Avg. wages/employee Rs Th565.3457.7 123.5%   
Avg. net profit/employee Rs Th105.41,141.8 9.2%   
INCOME DATA
Net Sales Rs m6,27949,463 12.7%  
Other income Rs m781,556 5.0%   
Total revenues Rs m6,35651,019 12.5%   
Gross profit Rs m49618,718 2.6%  
Depreciation Rs m1471,689 8.7%   
Interest Rs m3435 96.6%   
Profit before tax Rs m39318,551 2.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1495,023 3.0%   
Profit after tax Rs m24413,527 1.8%  
Gross profit margin %7.937.8 20.9%  
Effective tax rate %37.927.1 140.1%   
Net profit margin %3.927.3 14.2%  
BALANCE SHEET DATA
Current assets Rs m2,71746,501 5.8%   
Current liabilities Rs m1,5718,468 18.6%   
Net working cap to sales %18.376.9 23.7%  
Current ratio x1.75.5 31.5%  
Inventory Days Days32131 24.6%  
Debtors Days Days4786 54.3%  
Net fixed assets Rs m99125,797 3.8%   
Share capital Rs m141531 26.6%   
"Free" reserves Rs m2,37368,962 3.4%   
Net worth Rs m2,51469,493 3.6%   
Long term debt Rs m30-   
Total assets Rs m4,15880,383 5.2%  
Interest coverage x12.6531.0 2.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.50.6 245.4%   
Return on assets %6.716.9 39.6%  
Return on equity %9.719.5 49.8%  
Return on capital %16.926.7 63.3%  
Exports to sales %3.60-   
Imports to sales %0.524.6 2.0%   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m3112,187 0.3%   
Fx inflow Rs m22541,238 0.5%   
Fx outflow Rs m7112,405 0.6%   
Net fx Rs m15428,833 0.5%   
CASH FLOW
From Operations Rs m1739,543 1.8%  
From Investments Rs m97-6,854 -1.4%  
From Financial Activity Rs m-307-2,459 12.5%  
Net Cashflow Rs m-38230 -16.4%  

Share Holding

Indian Promoters % 65.4 52.0 125.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 11.8 31.4%  
FIIs % 5.2 19.0 27.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.2 150.0%  
Shareholders   12,723 31,796 40.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  ABBOTT INDIA  PLETHICO PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views on News

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Oct 17, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS